A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species

Table 1

The primers of each factor.

MMP9:	F:5-GCAGAGGCATACTTGTACCG-3
	R:5-TGATGTTATGATGGTCCCACTTG-3
CTSK:	F:5-CTCGGCGTTTAATTTGGGAGA-3
	R:5-TCGAGAGGGAGGTATTCTGAGT-3
RANK:	F: 5-TCCTCGGGAACTGGCTATG-3
	R:5-GGTTGGGTCCCATTGGAGAC-3
NFATC1:	F: 5-GGAGAGTCCGAGAATCGAGAT-3
	R:5-TTGCAGCTAGGAAGTACGTCT-3